Foghorn Therapeutics Inc.FHTXNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank71
3Y CAGR+15.7%
5Y CAGR-2.7%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+15.7%/yr
vs +6.9%/yr prior
5Y CAGR
-2.7%/yr
Recent acceleration
Acceleration
+8.8pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $80.88M | +45.8% |
| 2024 | $55.45M | -31.0% |
| 2023 | $80.34M | +53.9% |
| 2022 | $52.21M | -48.4% |
| 2021 | $101.14M | +9.0% |
| 2020 | $92.80M | +519.4% |
| 2019 | $14.98M | -62.6% |
| 2018 | $40.02M | - |